Thursday, August 25, 2016 12:53:18 PM
(just received):
"NanoLogix is pleased to announce the acceptance of the N-Assay research paper for peer-reviewed journal publication.
The research, conducted by physicians and laboratory personnel in Houston, Texas indicates that the N-Assay is the most accurate, sensitive, fastest, most comprehensive in its capabilities, and potentially the least expensive bacteria identification and diagnostic test ever developed.
Upon formal journal publication, a full transcript will be available on the NanoLogix website.
The Company also would like to announce that between now and October, there will be a completely revised website, with a primary focus upon this revolutionary N-Assay diagnostic technology and long life FlatPack petri plates."
Pretty BOLD statement on capabilities (no pun intended)
EI
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM